- Review
- OPEN ACCESS
-
Progress of research on tetrahydrocurcumin against liver injury
-
Ke-Yu Chen1,2,
-
Shuang Luo3,
-
Yun-Teng Liu3,
-
Xue Wang2 and
-
Jian-Bo Wang1,2,*
Author information
School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China
Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Academy of Chinese Medicine Sciences, Sichuan Institute for Translational Chinese Medicine, Chengdu 610041, China
College of Food and Biological Engineering, Chengdu University, Chengdu 610106, China
Correspondence to: Jian-Bo Wang, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China. E-mail:
yyswjb@fmmu.edu.cn
Abstract
Liver injury has become a serious liver disease worldwide, and its incidence is increasing year by year, bringing a serious health burden to people in all countries. Tetrahydrocurcumin is an active metabolite of curcumin, which has pharmacological effects such as antioxidant, anti-inflammatory, inhibition of apoptosis, anti-tumor, and anti-aging, and it can inhibit apoptosis in liver cells under the state of hepatic injury and reduce the level of oxidative stress and inflammation in liver tissues through the signaling pathways such as MAPK, PI3K/Akt, PPAR, AMPK, and Nrf2 to prevent and control liver injury. The purpose of preventing and controlling liver injury can be achieved. The active structure, pharmacological effects and application of tetrahydrocurcumin in liver injury were summarized by reviewing domestic and international literature, with a view to providing reference for further research on tetrahydrocurcumin in the field of liver injury.
Keywords
tetrahydrocurcumin,
active structure,
pharmacological effects,
liver injury
|
Copyright © 2025 Authors.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
About this Article
Cite this article
|
Chen KY, Luo S, Liu YT, Wang X, Wang JB. Progress of research on tetrahydrocurcumin against liver injury. Gastroenterol & Hepatol Res. 2023;5(3):14. doi: 10.53388/ghr2023-03-078.
|
| Copied to clipboard
|
Copy
Export to RIS
Export to EndNote
|
|
Citation copied!
|
Article History
| Received |
Revised |
Accepted |
Published |
|
|
|
|
September 21, 2023
|
DOI
http://dx.doi.org/10.53388/ghr2023-03-078
-
Gastroenterology & Hepatology Research
-
-
eISSN 2703-173X